Innate Pharma SA
Ivan Perrot is an experienced professional in the field of research and drug development, currently serving as the Director of Research & Drug Development at Innate Pharma since September 2005. Throughout tenure at Innate Pharma, Ivan has held various roles including Senior Program Manager in Drug Discovery and Scientist in Research & Development. Prior to this, Ivan worked at the Schering-Plough Research Institute as an Engineer in Research & Development from 1998 to 2004. Ivan holds a Doctor of Philosophy (PhD) in Immunology from Université Claude Bernard Lyon 1, earned between 2006 and 2009, and a degree in Ingénieur Génie Biologique from Polytech Clermont-Ferrand (ex-CUST), completed from 1995 to 1998.
This person is not in any teams
This person is not in any offices
Innate Pharma SA
2 followers
Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The Company develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. The Company works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The Company operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.